Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 2/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.51 |
| ▸ | ATIC | P31939 | 2/20 | 0.51 |
| ▸ | SENP2 | Q9HC62 | 5/20 | 0.50 |
| ▸ | SUMO2 | P61956 | 4/20 | 0.50 |
| ▸ | SUMO1 | P63165 | 4/20 | 0.50 |
| ▸ | SENP7 | Q9BQF6 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | NT5E | P21589 | 1/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.50 |
| ▸ | SENP1 | Q9P0U3 | 3/20 | 0.48 |
| ▸ | SENP3 | Q9H4L4 | 2/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | CD40 | P25942 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11128580 | 1.00 | ENPP2 (0.54) | ENPP2POLBCYP2D6RPS6KA3ATIC | |
| SCHEMBL11821612 | 0.92 | SUMO2 (0.50) | ENPP2POLBATICSENP2SUMO2 | |
| SCHEMBL11821604 | 0.92 | SUMO2 (0.50) | ENPP2POLBATICSENP2SUMO2 | |
| SCHEMBL6125347 | 0.88 | SENP2 (0.61) | ENPP2POLBCYP2D6RPS6KA3ATIC | |
| SCHEMBL13959639 | 0.87 | CD40 (0.56) | ENPP2ATICSENP2SUMO2SUMO1 | |
| SCHEMBL11765375 | 0.86 | SENP2 (0.61) | ENPP2POLBCYP2D6ATICSENP2 | |
| SCHEMBL10393912 | 0.84 | ENPP2 (0.58) | ENPP2ATICSENP2SUMO2SUMO1 | |
| SCHEMBL10393301 | 0.84 | ENPP2 (0.58) | ENPP2ATICSENP2SUMO2SUMO1 | |
| SCHEMBL9174992 | 0.84 | RPS6KA3 (0.50) | ENPP2POLBCYP2D6RPS6KA3ATIC | |
| SCHEMBL8746181 | 0.84 | RPS6KA3 (0.50) | ENPP2POLBCYP2D6RPS6KA3ATIC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-58021454-A | — | — | None | — | — | JP | disclosed |
| US-11110121-B2 | Compositions comprising hydrogen peroxide or hydrogen peroxide donor substances | CLARIANT INTERNATIONAL LTD. (CH) | 2021-09-07 | — | — | US | disclosed |
| US-10406135-B2 | Compositions containing isosorbide monoester and alcohols that contain at least one aromatic group | CLARIANT INTERNATIONAL LTD. (CH) | 2019-09-10 | — | — | US | disclosed |
| US-9834635-B2 | Polymers based on arcrylic, methacrylic or ethacrylic amidoalkyl sulfonic acid or salts and carboxyalky acrylate, methacrylate or ethacrylate or oligomers of said carboxy compounds | CLARIANT INTERNATIONAL LTD. (CH) | 2017-12-05 | — | — | US | disclosed |
| US-9592185-B2 | Compositions containing hydrogen peroxide or substances releasing hydrogen peroxide | CLARIANT INTERNATIONAL LTD. (CH) | 2017-03-14 | — | — | US | disclosed |
| US-9526687-B2 | Polymers based on sulfonic acids, amides and special cross-linking agents | CLARIANT INTERNATIONAL LTD. (CH) | 2016-12-27 | — | — | US | disclosed |
| US-9295626-B2 | Compositions comprising isosorbide monoester and N-hydroxypyridones | CLARIANT INTERNATIONAL LTD. (CH) | 2016-03-29 | — | — | US | disclosed |
| US-20160000080-A1 | COMPOSITIONS CONTAINING ISOSORBIDE MONOESTER AND ALIPHATIC VICINAL DIOLS | CLARIANT INTERNATIONAL LTD. (CH) | 2016-01-07 | — | — | US | disclosed |
| US-20150342856-A1 | Cationic Comb Copolymers, Preparation Thereof And Use Thereof In Cosmetic, Pharmaceutical And Dermatological Formulations | CLARIANT FINANCE (BVI) LIMITED (VG) | 2015-12-03 | — | — | US | disclosed |
| US-20140369943-A1 | COMPOSITIONS COMPRISING ISOSORBIDE MONOESTERS AND HALOGENATED ANTIMICROBIAL ACTIVE COMPOUNDS | CLARIANT INTERNATIONAL LTD. (CH) | 2014-12-18 | — | — | US | disclosed |
| US-20140086854-A1 | Polymers Based On Sulfonic Acids, Amides And Special Cross-Linking Agents | CLARIANT FINANCE (BVI) LIMITED (VG) | 2014-03-27 | — | — | US | disclosed |
| US-20130272984-A1 | Compositions Containing Hydrogen Peroxide Or Substances Releasing Hydrogen Peroxide | CLARIANT FINANCE (BVI) LIMITED (VG) | 2013-10-17 | — | — | US | disclosed |
| US-20120114571-A1 | Cationic Comb Copolymers, Preparation Thereof And Use Thereof In Cosmetic, Pharmaceutical And Dermatological Formulations | CLARIANT FINANCE (BVI) LIMITED (VG) | 2012-05-10 | — | — | US | disclosed |
| US-20120100084-A1 | POLYMERS BASED ON ARCRYLIC, METHACRYLIC OR ETHACRYLIC AMIDOALKYL SULFONIC ACID OR SALTS AND CARBOXYALKY ACRYLATE, METHACRYLATE OR ETHACRYLATE OR OLIGOMERS OF SAID CARBOXY COMPOUNDS | CLARIANT FINANCE (BVI) LIMITED (VG) | 2012-04-26 | — | — | US | disclosed |
| US-20110229427-A1 | Phosphoric Acid Esters Containing Phosphorus Atoms Bridged By Polyol Units | CLARIANT FINANCE (BVI) LIMITED (VG) | 2011-09-22 | — | — | US | disclosed |
| US-20110003010-A1 | Phosphoric Acid Esters Containing Phosphorus Atoms Bridged By Diol Units | CLARIANT FINANCE (BVI) LIMITED (VG) | 2011-01-06 | — | — | US | disclosed |
| US-20100260696-A1 | Aqueous Compositions Containing Alkoxylated Phosphoric Acid Triesters | CLARIANT FINANCE (BVI) LIMITED (VG) | 2010-10-14 | — | — | US | disclosed |
| US-20060188459-A1 | Cosmetic, pharmaceutical or dermatological preparations comprising copolymer waxes | HEINRICHS FRANZ-LEO | 2006-08-24 | — | — | US | disclosed |
| US-20060104940-A1 | Cosmetic, pharmaceutical and dermatological preparations comprising copolymer waxes | CLARIANT GMBH | 2006-05-18 | — | — | US | disclosed |
| JP-S5821454-A | TRISAZO BLACK REACTIVE DYE | SUMITOMO CHEM CO LTD | 1983-02-08 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (13 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130272984-A1 | Compositions Containing Hydrogen Peroxide Or Substances Releasing Hydrogen Peroxide | LPO, GPX4, HPGD | ENPP2 1842/4885POLB 238/4885CYP2D6 373/4885 |
| US-20120100084-A1 | POLYMERS BASED ON ARCRYLIC, METHACRYLIC OR ETHACRYLIC AMIDOALKYL SULFONIC ACID OR SALTS AND CARBOXYALKY ACRYLATE, METHACRYLATE OR ETHACRYLATE OR OLIGOMERS OF SAID CARBOXY COMPOUNDS | ASS1, ADSL, ACMSD | ENPP2 1026/4885POLB 1820/4885CYP2D6 2895/4885 |
| US-20060104940-A1 | Cosmetic, pharmaceutical and dermatological preparations comprising copolymer waxes | CUTA, ACMSD, DEGS1 | ENPP2 2523/4885POLB 245/4885CYP2D6 259/4885 |
| US-20100260696-A1 | Aqueous Compositions Containing Alkoxylated Phosphoric Acid Triesters | HAO2, HAO1, ALOX15B | ENPP2 72/4885POLB 293/4885CYP2D6 124/4885 |
| US-11110121-B2 | Compositions comprising hydrogen peroxide or hydrogen peroxide donor substances | GPX4, LPO, CAT | ENPP2 1968/4885POLB 147/4885CYP2D6 775/4885 |
| US-20140086854-A1 | Polymers Based On Sulfonic Acids, Amides And Special Cross-Linking Agents | ACMSD, SRM, TAS1R1 | ENPP2 4581/4885POLB 365/4885CYP2D6 2880/4885 |
| US-20160000080-A1 | COMPOSITIONS CONTAINING ISOSORBIDE MONOESTER AND ALIPHATIC VICINAL DIOLS | HSD17B12, DHCR7, ERG28 | ENPP2 2444/4885POLB 230/4885CYP2D6 213/4885 |
| US-20110003010-A1 | Phosphoric Acid Esters Containing Phosphorus Atoms Bridged By Diol Units | HAO2, HAO1, CYP24A1 | ENPP2 969/4885POLB 259/4885CYP2D6 300/4885 |
| US-20150342856-A1 | Cationic Comb Copolymers, Preparation Thereof And Use Thereof In Cosmetic, Pharmaceutical And Dermatological Formulations | C9, PARN, SGMS1 | ENPP2 2391/4885POLB 39/4885CYP2D6 1294/4885 |
| US-10406135-B2 | Compositions containing isosorbide monoester and alcohols that contain at least one aromatic group | ADH5, ADH1A, ADH1C | ENPP2 4450/4885POLB 344/4885CYP2D6 135/4885 |
| US-20140369943-A1 | COMPOSITIONS COMPRISING ISOSORBIDE MONOESTERS AND HALOGENATED ANTIMICROBIAL ACTIVE COMPOUNDS | FASN, HSD17B12, ELOVL3 | ENPP2 3487/4885POLB 52/4885CYP2D6 73/4885 |
| US-20120114571-A1 | Cationic Comb Copolymers, Preparation Thereof And Use Thereof In Cosmetic, Pharmaceutical And Dermatological Formulations | C9, PARN, SGMS1 | ENPP2 2069/4885POLB 54/4885CYP2D6 1346/4885 |
| US-20060188459-A1 | Cosmetic, pharmaceutical or dermatological preparations comprising copolymer waxes | CUTA, DEGS1, DSG1 | ENPP2 1278/4885POLB 539/4885CYP2D6 407/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.